Lin S - Search Results

1

Alternations of Blood Pressure Following Surgical or Drug Therapy for Prolactinomas.

Cheng Y, Wang D, Tang H, Tong D, Zhao W, Lin S, Yao H, Lv W, Zhang X, Xue L, Shang H, Wu ZB. Cheng Y, et al. Among authors: lin s. Cancers (Basel). 2024 Feb 9;16(4):726. doi: 10.3390/cancers16040726. Cancers (Basel). 2024. PMID: 38398117 Free PMC article.

2

High-mobility group box 2 is associated with prognosis of glioblastoma by promoting cell viability, invasion, and chemotherapeutic resistance.

Wu ZB, Cai L, Lin SJ, Xiong ZK, Lu JL, Mao Y, Yao Y, Zhou LF. Wu ZB, et al. Neuro Oncol. 2013 Sep;15(9):1264-75. doi: 10.1093/neuonc/not078. Epub 2013 Jul 4. Neuro Oncol. 2013. PMID: 23828241 Free PMC article.

3

The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas.

Wu ZB, Cai L, Lin SJ, Lu JL, Yao Y, Zhou LF. Wu ZB, et al. Brain Res. 2013 Sep 5;1529:16-25. doi: 10.1016/j.brainres.2013.07.031. Epub 2013 Jul 26. Brain Res. 2013. PMID: 23892108

4

CTL responses to HSP47 associated with the prolonged survival of patients with glioblastomas.

Wu ZB, Cai L, Qiu C, Zhang AL, Lin SJ, Yao Y, Xu J, Zhou LF. Wu ZB, et al. Neurology. 2014 Apr 8;82(14):1261-5. doi: 10.1212/WNL.0000000000000290. Epub 2014 Mar 12. Neurology. 2014. PMID: 24623841

5

MicroRNA expression profile of bromocriptine-resistant prolactinomas.

Wu ZB, Li WQ, Lin SJ, Wang CD, Cai L, Lu JL, Chen YX, Su ZP, Shang HB, Yang WL, Zhao WG. Wu ZB, et al. Mol Cell Endocrinol. 2014 Sep;395(1-2):10-8. doi: 10.1016/j.mce.2014.07.014. Epub 2014 Jul 23. Mol Cell Endocrinol. 2014. PMID: 25064468 Clinical Trial.

6

Glioma-associated antigen HEATR1 induces functional cytotoxic T lymphocytes in patients with glioma.

Wu ZB, Qiu C, Zhang AL, Cai L, Lin SJ, Yao Y, Tang QS, Xu M, Hua W, Chu YW, Mao Y, Zhu JH, Xu J, Zhou LF. Wu ZB, et al. J Immunol Res. 2014;2014:131494. doi: 10.1155/2014/131494. Epub 2014 Jul 9. J Immunol Res. 2014. PMID: 25126583 Free PMC article.

7

Heat Shock Protein 47 Promotes Glioma Angiogenesis.

Wu ZB, Cai L, Lin SJ, Leng ZG, Guo YH, Yang WL, Chu YW, Yang SH, Zhao WG. Wu ZB, et al. Brain Pathol. 2016 Jan;26(1):31-42. doi: 10.1111/bpa.12256. Epub 2015 May 7. Brain Pathol. 2016. PMID: 25758142 Free PMC article.

8

Suppression of mTOR pathway and induction of autophagy-dependent cell death by cabergoline.

Lin SJ, Leng ZG, Guo YH, Cai L, Cai Y, Li N, Shang HB, Le WD, Zhao WG, Wu ZB. Lin SJ, et al. Oncotarget. 2015 Nov 17;6(36):39329-41. doi: 10.18632/oncotarget.5744. Oncotarget. 2015. PMID: 26513171 Free PMC article.

9

Dopamine agonist resistance-related endocan promotes angiogenesis and cells viability of prolactinomas.

Cai L, Leng ZG, Guo YH, Lin SJ, Wu ZR, Su ZP, Lu JL, Wei LF, Zhuge QC, Jin K, Wu ZB. Cai L, et al. Endocrine. 2016 Jun;52(3):641-51. doi: 10.1007/s12020-015-0824-2. Epub 2015 Dec 12. Endocrine. 2016. PMID: 26662185

10

Long-Term Clinical Outcomes of Invasive Giant Prolactinomas after a Mean Ten-Year Followup.

Wu ZR, Zhang Y, Cai L, Lin SJ, Su ZP, Wei YX, Shang HB, Yang WL, Zhao WG, Wu ZB. Wu ZR, et al. Int J Endocrinol. 2016;2016:8580750. doi: 10.1155/2016/8580750. Epub 2016 Nov 23. Int J Endocrinol. 2016. PMID: 27999593 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30,652 results

Search Page